Status:
NOT_YET_RECRUITING
Different Methods of Tranexamic Acid Application in Controlling Peri Operative Bleeding in Gynecomastia Surgery
Lead Sponsor:
Assiut University
Conditions:
Pharmacological-Aggravated Urticaria
Eligibility:
MALE
16-45 years
Phase:
EARLY_PHASE1
Brief Summary
Different Methods of Tranexamic Acid Application in Controlling Peri-Operative Bleeding in Gynecomastia Surgery
Detailed Description
The term "gynecomastia" is derived from the Greek words "gyne" = woman and "mastos" = breast and is a benign enlargement of the male breast. It is the most common condition affecting the male breast d...
Eligibility Criteria
Inclusion
- Age (16 - 45 years)
- Any grade of gynecomastia well be included
Exclusion
- Age (\<16 - \>40 years)
- History of previous gynecomastia surgery
- Patients with known allergy to tranexamic acid
- Patients with abnormal coagulation profile (according to American Society of Anesthesiologists guidelines for preoperative preparation of surgical patients)
- Patients who are receiving treatment for known hyper-coagulable state. 6. Patients with history of cardiac disease or thromboembolic events.
Key Trial Info
Start Date :
July 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 20 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06509256
Start Date
July 20 2024
End Date
April 20 2025
Last Update
July 19 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.